drugset / Trial / NCT02322528
Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to evaluate the effects of an anti-inflammatory drug (Lotemax®) on the surface of the eye and tear film (a film that coats the eye which is made up of oil and water).
Timeline
- Start
- 2014-04
- Primary completion
- 2015-08
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Loteprednol Etabonate | Other / unclassified | — | — |